Charles N II York
CIK 1655962 · COO and CFO · last filed 2026-04-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
42
Lifetime Open-Market Net
-$3.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Day One Biopharmaceuticals, Inc. (DAWN) Delisted | COO and CFO | 0 | $21.53 | $0 | -$3.32M | 34 | 2026-04-23 |
| Spyre Therapeutics, Inc. (AGLE) Delisted | Chief Financial Officer and VP | 46,347 | $12.01 | $556.6K | $116.2K | 8 | 2020-02-19 |
Recent Filings · Page 2 of 5
42 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-19 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Mixed | +7,617 | -$36.9K | EDGAR |
| 2024-05-17 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Mixed | +7,575 | -$43.0K | EDGAR |
| 2024-05-03 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Sell (S) | −60,461 | -$1.08M | EDGAR |
| 2024-02-20 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Mixed | +7,584 | -$40.7K | EDGAR |
| 2024-01-09 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-11-17 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Mixed | +2,669 | -$11.2K | EDGAR |
| 2023-08-17 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Mixed | +2,703 | -$12.8K | EDGAR |
| 2023-05-17 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Mixed | +2,670 | -$12.5K | EDGAR |
| 2023-02-21 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Sell (S) | −9,377 | -$187.8K | EDGAR |
| 2023-02-17 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Mixed | +2,695 | -$18.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.